| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 6 | 2016 | 441 | 1.360 |
Why?
|
| Echocardiography, Doppler | 3 | 2020 | 166 | 0.770 |
Why?
|
| Aorta | 2 | 2016 | 529 | 0.730 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2017 | 163 | 0.570 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2017 | 11 | 0.520 |
Why?
|
| Heart Ventricles | 6 | 2022 | 769 | 0.520 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2017 | 27 | 0.520 |
Why?
|
| Heart Septal Defects, Ventricular | 5 | 2018 | 133 | 0.500 |
Why?
|
| Echocardiography | 11 | 2022 | 1138 | 0.490 |
Why?
|
| Tetralogy of Fallot | 3 | 2015 | 176 | 0.460 |
Why?
|
| Heart Diseases | 2 | 2020 | 505 | 0.460 |
Why?
|
| Carotid Artery, Internal | 1 | 2015 | 55 | 0.440 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 325 | 0.390 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2022 | 359 | 0.390 |
Why?
|
| Cyanosis | 2 | 2015 | 42 | 0.370 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 463 | 0.370 |
Why?
|
| Heart Defects, Congenital | 7 | 2015 | 1894 | 0.340 |
Why?
|
| Mass Screening | 1 | 2017 | 825 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2008 | 3917 | 0.310 |
Why?
|
| Pericardial Effusion | 2 | 2025 | 72 | 0.280 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2005 | 165 | 0.270 |
Why?
|
| Pulmonary Atresia | 1 | 2007 | 48 | 0.260 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2007 | 61 | 0.260 |
Why?
|
| Heart Neoplasms | 1 | 2008 | 107 | 0.250 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2007 | 92 | 0.250 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2008 | 163 | 0.250 |
Why?
|
| Leg | 1 | 2007 | 123 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 647 | 0.240 |
Why?
|
| Mitral Valve | 1 | 2007 | 249 | 0.230 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2008 | 1356 | 0.230 |
Why?
|
| Venae Cavae | 1 | 2005 | 10 | 0.230 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 28 | 0.230 |
Why?
|
| Coronary Aneurysm | 1 | 2005 | 31 | 0.230 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2005 | 122 | 0.220 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 74 | 0.210 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2007 | 276 | 0.210 |
Why?
|
| Infant | 15 | 2025 | 13306 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 5297 | 0.210 |
Why?
|
| Esophagogastric Junction | 1 | 2004 | 36 | 0.210 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 148 | 0.200 |
Why?
|
| Pulmonary Veins | 1 | 2005 | 169 | 0.200 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2007 | 284 | 0.200 |
Why?
|
| Coronary Vessels | 1 | 2007 | 529 | 0.200 |
Why?
|
| Humans | 38 | 2025 | 131679 | 0.200 |
Why?
|
| Heart Atria | 2 | 2020 | 336 | 0.190 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2002 | 4 | 0.190 |
Why?
|
| Anorexia Nervosa | 1 | 2002 | 31 | 0.190 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2004 | 225 | 0.180 |
Why?
|
| Ventricular Function, Right | 1 | 2022 | 126 | 0.170 |
Why?
|
| Male | 24 | 2025 | 65266 | 0.170 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 974 | 0.170 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 516 | 0.170 |
Why?
|
| Anthracyclines | 1 | 2020 | 43 | 0.160 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 36 | 0.160 |
Why?
|
| Kidney | 1 | 2007 | 1309 | 0.160 |
Why?
|
| Myocarditis | 1 | 2021 | 130 | 0.150 |
Why?
|
| Heart Failure | 3 | 2007 | 2307 | 0.150 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 125 | 0.150 |
Why?
|
| Adolescent | 14 | 2025 | 20982 | 0.150 |
Why?
|
| Ultrasonography | 4 | 2007 | 974 | 0.140 |
Why?
|
| Child, Preschool | 12 | 2025 | 15057 | 0.140 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 65 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2017 | 17 | 0.140 |
Why?
|
| Glucosidases | 1 | 2017 | 3 | 0.130 |
Why?
|
| Acarbose | 1 | 2017 | 7 | 0.130 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2017 | 6 | 0.130 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2016 | 1 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 1 | 2016 | 53 | 0.120 |
Why?
|
| Cancer Survivors | 1 | 2020 | 268 | 0.120 |
Why?
|
| Noonan Syndrome | 1 | 2016 | 33 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2025 | 1263 | 0.120 |
Why?
|
| Neoplasms | 2 | 2022 | 2969 | 0.120 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 1911 | 0.120 |
Why?
|
| Female | 17 | 2025 | 71185 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2021 | 1075 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2018 | 1006 | 0.120 |
Why?
|
| Transposition of Great Vessels | 3 | 2005 | 126 | 0.110 |
Why?
|
| Point Mutation | 1 | 2016 | 339 | 0.110 |
Why?
|
| Infant, Newborn | 8 | 2021 | 8589 | 0.110 |
Why?
|
| Treatment Outcome | 7 | 2020 | 12984 | 0.110 |
Why?
|
| Peripheral Nerves | 1 | 1995 | 88 | 0.110 |
Why?
|
| Spinal Neoplasms | 1 | 1995 | 74 | 0.110 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 214 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 1995 | 109 | 0.110 |
Why?
|
| Child | 14 | 2025 | 26299 | 0.110 |
Why?
|
| Sarcoma, Ewing | 1 | 1995 | 117 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 1995 | 146 | 0.100 |
Why?
|
| Radiography | 2 | 2015 | 762 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1995 | 137 | 0.100 |
Why?
|
| Angiography | 2 | 2005 | 188 | 0.100 |
Why?
|
| Prognosis | 2 | 2017 | 4952 | 0.100 |
Why?
|
| Ethics Committees | 1 | 1993 | 3 | 0.100 |
Why?
|
| Ethics | 1 | 1993 | 22 | 0.100 |
Why?
|
| Ethics Consultation | 1 | 1993 | 27 | 0.090 |
Why?
|
| Professional Role | 1 | 1993 | 76 | 0.090 |
Why?
|
| Ethicists | 1 | 1993 | 50 | 0.090 |
Why?
|
| Professional Competence | 1 | 1993 | 94 | 0.090 |
Why?
|
| Hospitalization | 1 | 2021 | 1939 | 0.090 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1999 | 699 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2025 | 17667 | 0.080 |
Why?
|
| Brain | 1 | 2002 | 3239 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 2297 | 0.070 |
Why?
|
| Young Adult | 2 | 2025 | 10104 | 0.070 |
Why?
|
| Computer Systems | 1 | 2007 | 36 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 216 | 0.070 |
Why?
|
| Adult | 7 | 2018 | 31719 | 0.070 |
Why?
|
| Hydronephrosis | 1 | 2007 | 36 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 67 | 0.060 |
Why?
|
| Pelvis | 1 | 2007 | 70 | 0.060 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 84 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2006 | 86 | 0.060 |
Why?
|
| Tachycardia, Sinus | 1 | 2005 | 6 | 0.060 |
Why?
|
| Heart Murmurs | 1 | 2005 | 13 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2008 | 316 | 0.060 |
Why?
|
| Incidence | 2 | 2025 | 3347 | 0.060 |
Why?
|
| Tricuspid Atresia | 1 | 2005 | 14 | 0.060 |
Why?
|
| Electrocardiography | 3 | 2005 | 983 | 0.060 |
Why?
|
| Long-Term Care | 1 | 2005 | 70 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2005 | 147 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1610 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2005 | 175 | 0.050 |
Why?
|
| Warfarin | 1 | 2005 | 123 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 1322 | 0.050 |
Why?
|
| Aspirin | 1 | 2005 | 216 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2006 | 215 | 0.050 |
Why?
|
| Mutation | 1 | 2017 | 6177 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 326 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2003 | 57 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 154 | 0.050 |
Why?
|
| Fever | 1 | 2005 | 311 | 0.050 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2002 | 24 | 0.050 |
Why?
|
| Evoked Potentials, Visual | 1 | 2002 | 33 | 0.050 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2003 | 70 | 0.050 |
Why?
|
| Evoked Potentials, Motor | 1 | 2002 | 31 | 0.050 |
Why?
|
| Spine | 1 | 2003 | 148 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2006 | 481 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 81 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2003 | 156 | 0.050 |
Why?
|
| Systole | 1 | 2022 | 197 | 0.040 |
Why?
|
| Acute Disease | 2 | 2021 | 1153 | 0.040 |
Why?
|
| Myocardium | 1 | 2006 | 874 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 531 | 0.040 |
Why?
|
| Cineangiography | 1 | 1999 | 15 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2021 | 180 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 547 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1517 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 3695 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2018 | 116 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1999 | 145 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 1999 | 457 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 1999 | 224 | 0.030 |
Why?
|
| Texas | 1 | 2025 | 3622 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 364 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1224 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 1170 | 0.030 |
Why?
|
| Pregnancy | 2 | 2018 | 7572 | 0.030 |
Why?
|
| Gestational Age | 1 | 1999 | 1221 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1399 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2989 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1995 | 197 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 1995 | 215 | 0.030 |
Why?
|
| Risk Factors | 2 | 2025 | 10959 | 0.030 |
Why?
|
| Age Factors | 3 | 2008 | 2872 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1999 | 539 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 3101 | 0.030 |
Why?
|
| Democracy | 1 | 1993 | 2 | 0.020 |
Why?
|
| Social Dominance | 1 | 1993 | 11 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3454 | 0.020 |
Why?
|
| Freedom | 1 | 1993 | 17 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2143 | 0.020 |
Why?
|
| Education | 1 | 1993 | 113 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1502 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 1993 | 132 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 1260 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1993 | 152 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3834 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 1993 | 206 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1995 | 1454 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6279 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5123 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 4516 | 0.020 |
Why?
|
| Decision Making | 1 | 1993 | 684 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 570 | 0.020 |
Why?
|
| Troponin | 1 | 2006 | 70 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2006 | 144 | 0.010 |
Why?
|
| United States | 1 | 2021 | 11804 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2006 | 6494 | 0.010 |
Why?
|
| Reoperation | 1 | 2008 | 844 | 0.010 |
Why?
|
| Angiocardiography | 1 | 2002 | 9 | 0.010 |
Why?
|
| Tachycardia | 1 | 2003 | 71 | 0.010 |
Why?
|
| Heart Bypass, Right | 1 | 2002 | 18 | 0.010 |
Why?
|
| Aortic Coarctation | 1 | 2004 | 98 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 2151 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 130 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 397 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2003 | 173 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 613 | 0.010 |
Why?
|
| Hypotension | 1 | 2003 | 185 | 0.010 |
Why?
|
| Heart Rate | 1 | 2003 | 580 | 0.010 |
Why?
|
| Palliative Care | 1 | 2004 | 444 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 1999 | 23 | 0.010 |
Why?
|
| Retreatment | 1 | 1999 | 87 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2002 | 635 | 0.010 |
Why?
|
| Equipment Design | 1 | 1999 | 555 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2008 | 3130 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 21260 | 0.000 |
Why?
|